Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:carboplatin (1:1 mol/mol) |
PharmacoGx | BRD-A02303741:carboplatin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLXNA3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | SLC6A3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ACAP3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | FAH | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | KRTAP13-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | EML5 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
mRNA | LMBR1L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | DHX16 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | TCP11L2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | FAM129A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |